DM

Deerfield Management Portfolio holdings

AUM $5.51B
This Quarter Return
+16.43%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.68B
AUM Growth
+$4.68B
Cap. Flow
-$330M
Cap. Flow %
-7.05%
Top 10 Hldgs %
50.13%
Holding
123
New
17
Increased
19
Reduced
10
Closed
18

Top Buys

1
APLS icon
Apellis Pharmaceuticals
APLS
$28.5M
2
AMED
Amedisys
AMED
$28.4M
3
RVMD icon
Revolution Medicines
RVMD
$24.7M
4
CABA icon
Cabaletta Bio
CABA
$24.2M
5
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
$23M

Top Sells

1
NBIX icon
Neurocrine Biosciences
NBIX
$50.5M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
$48.8M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
$39.7M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$36.6M
5
EOLS icon
Evolus
EOLS
$30.2M

Sector Composition

1 Healthcare 68.03%
2 Financials 0.35%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NAMS icon
26
NewAmsterdam Pharma
NAMS
$2.8B
$30.1M 0.64%
2,535,723
– –
DCGO icon
27
DocGo
DCGO
$152M
$28.7M 0.61%
3,059,000
– –
APLS icon
28
Apellis Pharmaceuticals
APLS
$3.51B
$28.5M 0.61%
+313,289
New +$28.5M
GPCR icon
29
Structure Therapeutics
GPCR
$1.14B
$26.1M 0.56%
627,813
+252,813
+67% +$10.5M
ICPT
30
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$23M 0.49%
+2,077,893
New +$23M
AMLX icon
31
Amylyx Pharmaceuticals
AMLX
$877M
$22.7M 0.48%
1,050,198
-934,135
-47% -$20.1M
RVNC
32
DELISTED
Revance Therapeutics, Inc.
RVNC
$22M 0.47%
+870,000
New +$22M
ATEC icon
33
Alphatec Holdings
ATEC
$2.35B
$21.4M 0.46%
1,189,648
+142,857
+14% +$2.57M
VTYX icon
34
Ventyx Biosciences
VTYX
$184M
$20.2M 0.43%
617,000
– –
VIGL
35
DELISTED
Vigil Neuroscience
VIGL
$19.3M 0.41%
2,052,010
– –
IRON icon
36
Disc Medicine
IRON
$2.14B
$19.1M 0.41%
+430,000
New +$19.1M
VKTX icon
37
Viking Therapeutics
VKTX
$3.02B
$18.2M 0.39%
1,125,000
– –
DNLI icon
38
Denali Therapeutics
DNLI
$2.24B
$17.6M 0.37%
594,989
– –
TERN icon
39
Terns Pharmaceuticals
TERN
$651M
$16.6M 0.35%
1,898,743
-160,678
-8% -$1.41M
DALS
40
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$16.4M 0.35%
1,600,000
– –
DAWN icon
41
Day One Biopharmaceuticals
DAWN
$766M
$15.2M 0.32%
+1,269,992
New +$15.2M
MLYS icon
42
Mineralys Therapeutics
MLYS
$1.94B
$14.3M 0.3%
837,000
+107,979
+15% +$1.84M
LUNG icon
43
Pulmonx
LUNG
$67.6M
$14M 0.3%
1,064,285
-1,338,419
-56% -$17.5M
INSM icon
44
Insmed
INSM
$30.3B
$13.9M 0.3%
658,546
– –
ROIV icon
45
Roivant Sciences
ROIV
$8.6B
$13.7M 0.29%
1,354,974
-395,026
-23% -$3.98M
SLRN
46
DELISTED
ACELYRIN
SLRN
$13.6M 0.29%
+650,000
New +$13.6M
FUSN
47
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$13.2M 0.28%
2,823,000
– –
THRX
48
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$13.1M 0.28%
+1,400,352
New +$13.1M
PRME icon
49
Prime Medicine
PRME
$595M
$13M 0.28%
885,314
– –
ANAB icon
50
AnaptysBio
ANAB
$630M
$12.5M 0.27%
613,000
– –
1
2
3 4 5